Erlinda R. Ulloa

Erlinda R. Ulloa, MD is an Assistant Professor in the Department of Pediatrics at the University of California, Irvine School of Medicine. She holds a joint appointment in the Department of Microbiology & Molecular Genetics and is affiliated with the Division of Infectious Diseases in Medicine. Her research focuses on antimicrobial strategies against Staphylococcus aureus infections, particularly the role of platelets in bacterial clearance and mortality reduction. Dr. Ulloa has contributed to studies demonstrating how P2Y12 inhibitors like clopidogrel and ticagrelor improve clinical outcomes in S. aureus bacteremia by mitigating platelet depletion and reducing mortality. Her work integrates microbiology, immunology, and clinical pharmacology to address infectious disease challenges. Recent studies emphasize neutrophil extracellular traps as emerging therapeutic targets. She has published in high-impact journals such as the Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.